20 Worst Paying Jobs For Women

Gender equality has taken a more central role in the American political and cultural discourse in recent years. One of the chief targets in the fight for gender equality is ...
Read Full Story »

Hero Humanitarians You Should Know About Now

Working to help others and improve the community is, for many, part of what it means to be human. An army of workers and volunteers work every day to ...
Read Full Story »

J.C. Penney Analyst Downgrade Brigade Looks Atrocious

  J.C. Penney Company, Inc. (NYSE: JCP) is in the midst of a crisis. After poor earnings rattled the stock, most of its investors and customers have to be ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

August 16, 2018: The S&P 500 closed up 0.8% at 2,840.75. The DJIA closed up 1.6% at 25,558.87. Separately, the Nasdaq was up 0.4% at 7,806.52. Thursday was a very ...
Read Full Story »

JC Penney, JD.com Fall into Thursday’s 52-Week Low Club

August 16, 2018: Here are four stocks trading with heavy volume among 122 equities making new 52-week lows in Thursday's session. On the NYSE advancers led decliners by about 2.93 ...
Read Full Story »

Walmart, Boeing Boost the Dow Thursday

August 16, 2018: Markets opened higher Thursday following solid earnings reports from two Dow stocks. Cisco beat estimates and Walmart did the same plus it boosted guidance. Reports that the ...
Read Full Story »

Are Teva and Mylan Entering an EpiPen Price War to Zero?

Mylan N.V. (NASDAQ: MYL) has had a stranglehold on the market for EpiPen, but this is all changing after the U.S. Food and Drug Administration (FDA) approved Teva Pharmaceutical Ltd. ...
Read Full Story »

The Rust Belt Needs Capital to Turn Talent and Innovation Into Jobs

By John C. Austin, nonresident senior fellow in the Metropolitan Policy Program at the Brookings Institution Since Rust Belt voters tipped the results of the 2016 election, interest in effective ...
Read Full Story »

New Osteoarthritis Treatment Could Precipitate Another Blockbuster Drug

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of ...
Read Full Story »

The Driving Force for Even Higher Growth at Lululemon Might Not Be What You Think

Should analysts indefinitely chase up their ratings and targets on companies they follow? It's rather complicated, but this is a scenario that many investors find themselves contemplating if they have ...
Read Full Story »

July Housing Starts Resume Slow Growth

The U.S. Census Bureau and the Department of Housing and Urban Development reported Thursday morning that new housing starts in July rose to a seasonally adjusted annual rate of 1.168 ...
Read Full Story »

The Cost of a Wedding in Every State

Weddings are ideally a once-in-a-lifetime celebration of love, so brides and grooms are often willing to spend a small fortune on the big day. According to wedding industry research company ...
Read Full Story »

What to Expect When Nvidia Reports After the Close

Nvidia Corp. (NASDAQ: NVDA) is scheduled to release its fiscal second-quarter financial results after the markets close on Thursday. The consensus estimates are $1.66 in earnings per share (EPS) and ...
Read Full Story »

Why Canopy Growth Received a Speculative Buy Analyst Rating With Big Upside

Wednesday's market sell-off may have gone unnoticed by investors who have opted to invest in (or speculate in) some of the more widely known cannabis companies. Canopy Growth Corp. (NYSE: ...
Read Full Story »

Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares saw a handy gain on Thursday after the U.S. Food and Drug Administration (FDA) gave the nod to Vertex’s cystic fibrosis (CF) treatment. Essentially, ...
Read Full Story »